232 related articles for article (PubMed ID: 22889982)
1. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
[TBL] [Abstract][Full Text] [Related]
2. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
3. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
4. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
Yun SP; Seo HI
BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
Zhou H; Schaefer N; Wolff M; Fischer HP
Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of carcinoma of the papilla of Vater.
Fischer HP; Zhou H
J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
10. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.
Robert PE; Leux C; Ouaissi M; Miguet M; Paye F; Merdrignac A; Delpero JR; Schwarz L; Carrere N; Muscari F; Gayet B; Dussart D; Hamy A; Regenet N
Pancreas; 2014 Jul; 43(5):692-7. PubMed ID: 24713843
[TBL] [Abstract][Full Text] [Related]
11. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of serum CA19-9 as a prognostic factor for the ampulla of Vater carcinoma.
Kurihara C; Yoshimi F; Sasaki K; Iijima T; Kawasaki H; Nagai H
Hepatogastroenterology; 2013 Oct; 60(127):1588-91. PubMed ID: 23933785
[TBL] [Abstract][Full Text] [Related]
13. Does ampullary carcinoma arise from distended glands in the papilla of Vater?
Sonoue H; Suda K; Nobukawa B; Abe H; Arakawa A; Hirai S; Matsumoto T
J Hepatobiliary Pancreat Surg; 2008; 15(2):161-8. PubMed ID: 18392709
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
Kawabata Y; Tanaka T; Nishisaka T; Inao T; Nishi T; Yano S
Diagn Pathol; 2010 Nov; 5():75. PubMed ID: 21106111
[TBL] [Abstract][Full Text] [Related]
15. [Determinants of long-term survival after pancreaticoduodenectomy for ampulla of Vater carcinoma].
Chen JY; Cai SW; Zhang WZ; Huang XQ; Liu R; Wang J; Chen YL; Ji WB; Shi XJ; Chen MY; Liu ZW; Zhao XQ; Feng YQ; Huang ZQ; Dong JH
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(48):3409-12. PubMed ID: 20223115
[TBL] [Abstract][Full Text] [Related]
16. Pathologic T1 subclassification of ampullary carcinoma with perisphincteric or duodenal submucosal invasion: Is it T1b?
You D; Heo J; Choi S; Choi D; Jang KT
Arch Pathol Lab Med; 2014 Aug; 138(8):1072-6. PubMed ID: 25076296
[TBL] [Abstract][Full Text] [Related]
17. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
18. [Results of cephalic pancreaticoduodenectomy for ampullary carcinoma. Analysis of 18 consecutive cases].
Casaretto E; Andrada DG; Granero LE
Acta Gastroenterol Latinoam; 2010 Mar; 40(1):22-31. PubMed ID: 20446393
[TBL] [Abstract][Full Text] [Related]
19. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]